Athersys Announces Authorization of Stem Cell Clinical Trial for Stroke in the United Kingdom

[at noodls] – MHRA Authorizes Athersys to Expand Ongoing Phase 2 Clinical Trial of MultiStem Cell Therapy in Ischemic Stroke CLEVELAND, April 17, 2013 (GLOBE NEWSWIRE) — Athersys, Inc. (Nasdaq:ATHX) announced today … more

View todays social media effects on ATHX

View the latest stocks trending across Twitter. Click to view dashboard

See who Athersys is hiring next, click here to view